This information is likely to influence current algorithms for evaluating patients with pleural effusion, especially with the development of a low-cost ultrasensitive rapid immuno-suspension test that could lead to wider deployment of pleural fluid IFN-γ assays [63]. This evidence concerns the gene IFNG and Pleural effusion.